Top news and stories from EWORLDWIRE http://www.eworldwire.com/ http://www.eworldwire.com/logos/logo40x60.gif http://www.eworldwire.com/ 40 60 (C) Copyright 2007 EWORLDWIRE Wed, 05 Sep 2007 16:12:01 -0400 http://www.eworldwire.com/pressreleases/10424 Cytorex Biosciences Inc. reports it has concluded cytotoxicity testing in cancer and healthy cell cultures with its proprietary compound Cytoreg(R), with selective cytotoxicity activity against cancer cells, high anti-oxidant and free radical stress capability. In healthy cells tested at the same doses as cancer cells the cytotoxicity profile is very low, making Cytoreg(R) a potential safe and effective first line agent for the treatment of different cancer indications. [EWORLDWIRE] Wed, 07 Jul 2004 08:59:24 -0400